150 related articles for article (PubMed ID: 8512807)
1. Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.
Nouri AM; Hussain RF; Dos Santos AV; Mansouri M; Oliver RT
Br J Cancer; 1993 Jun; 67(6):1223-8. PubMed ID: 8512807
[TBL] [Abstract][Full Text] [Related]
2. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
3. Super-sensitive epithelial cell line and colorimetric assay to replace the conventional K562 target and chromium release assay for assessment of non-MHC-restricted cytotoxicity.
Nouri AM; Mansouri M; Hussain RF; Dos Santos AV; Oliver RT
J Immunol Methods; 1995 Mar; 180(1):63-8. PubMed ID: 7534804
[TBL] [Abstract][Full Text] [Related]
4. A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells.
Lobo PI; Patel HC
Immunology; 1994 Oct; 83(2):240-4. PubMed ID: 7835941
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Nouri AM; Symes MO
Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
[TBL] [Abstract][Full Text] [Related]
6. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis.
Lobo PI; Chang MY; Mellins E
Immunology; 1996 Aug; 88(4):625-9. PubMed ID: 8881767
[TBL] [Abstract][Full Text] [Related]
8. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
9. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity.
Jabrane-Ferrat N; Calvo F; Faille A; Lagabrielle JF; Boisson N; Quillet A; Fradelizi D
Br J Cancer; 1990 Apr; 61(4):558-62. PubMed ID: 2109997
[TBL] [Abstract][Full Text] [Related]
10. NK and LAK susceptibility varies inversely with target cell MHC class I antigen expression in a rat epithelial tumour system.
Carbone E; Racioppi L; La Cava A; Portella G; Velotti F; Zappacosta S; Fontana S
Scand J Immunol; 1991 Feb; 33(2):185-94. PubMed ID: 2017656
[TBL] [Abstract][Full Text] [Related]
11. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
[TBL] [Abstract][Full Text] [Related]
12. Bovine NK and LAK susceptibility is independent of class I expression on B lymphoblastoid variants.
Li W; Splitter GA
Vet Immunol Immunopathol; 1994 Jun; 41(3-4):189-200. PubMed ID: 7941303
[TBL] [Abstract][Full Text] [Related]
13. Accurate and rapid assessment of MHC antigen upregulation following cytokine stimulation.
Gillott DJ; Nouri AM; Compton SJ; Oliver RT
J Immunol Methods; 1993 Oct; 165(2):231-9. PubMed ID: 8228273
[TBL] [Abstract][Full Text] [Related]
14. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
15. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis.
Chiang EY; Henson M; Stroynowski I
J Immunol; 2002 Mar; 168(5):2200-11. PubMed ID: 11859106
[TBL] [Abstract][Full Text] [Related]
16. Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing.
Maziarz RT; Groh V; Prendergast M; Fabbi M; Strominger JL; Burakoff SJ
Int J Cancer; 1991 Apr; 48(1):142-7. PubMed ID: 1902200
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-induced protection of tumour cell susceptibility to cytolysis.
Nouri AM; Hussain RF; Oliver RT
Eur J Cancer; 1995 Jun; 31A(6):963-9. PubMed ID: 7544146
[TBL] [Abstract][Full Text] [Related]
18. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
Reiter Z
J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
[TBL] [Abstract][Full Text] [Related]
19. Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Ohno T
J Hematother; 1999 Feb; 8(1):29-37. PubMed ID: 10192299
[TBL] [Abstract][Full Text] [Related]
20. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]